SCHEMBL734336

SCHEMBL734336

CC1(C)OB(c2cc3ccccc3c3ccccc23)OC1(C)C

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LPL P06858 5/20 0.45
LIPG Q9Y5X9 5/20 0.45
TRPM4 Q8TD43 1/20 0.38
ALDH1A1 P00352 4/20 0.38
HSD17B10 Q99714 3/20 0.38
HIF1A Q16665 1/20 0.38
CYP1B1 Q16678 1/20 0.38
HPRT1 P00492 1/20 0.35
CYP1A2 P05177 3/20 0.35
ERBB2 P04626 1/20 0.35
FYN P06241 1/20 0.35
MAOA P21397 1/20 0.35
ACHE P22303 1/20 0.35
AHR P35869 1/20 0.35
HPGD P15428 2/20 0.35
MAPT P10636 1/20 0.35
CYP2A6 P11509 2/20 0.33
TSHR P16473 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
ANPEP P15144 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31357522 0.88 HPRT1 (0.45) LPLLIPGALDH1A1HSD17B10HIF1A
SCHEMBL2228172 0.88 HPRT1 (0.45) LPLLIPGALDH1A1HSD17B10HIF1A
SCHEMBL10015033 0.87 LPL (0.44) LPLLIPGANPEPLAP3
SCHEMBL23625559 0.86 LPL (0.38) LPLLIPGTRPM4ALDH1A1HSD17B10
SCHEMBL31292620 0.85 LPL (0.40) LPLLIPGTRPM4ALDH1A1HSD17B10
SCHEMBL20236050 0.85 LPL (0.40) LPLLIPGTRPM4ALDH1A1HSD17B10
SCHEMBL17300256 0.84 LPL (0.39) LPLLIPGALDH1A1HSD17B10HIF1A
SCHEMBL476903 0.83 HPRT1 (0.47) LPLLIPGALDH1A1HSD17B10HIF1A
SCHEMBL20017911 0.83 CYP1A2 (0.47) LPLLIPGALDH1A1HSD17B10HIF1A
SCHEMBL22555118 0.83 LPL (0.43) LPLLIPGALDH1A1HSD17B10HIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 151 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12167689-B2 Heterocyclic compound and organic light emitting device comprising the same LG CHEM, LTD. (KR) 2024-12-10 US disclosed
US-12091401-B2 Nitrogen-heterocyclic compound, display panel and display apparatus WUHAN TIANMA MICRO-ELECTRONICS CO., LTD. (CN) 2024-09-17 US disclosed
WO-2024151024-A1 COMPOUND FOR CAPPING LAYER AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME 주식회사 진웅산업 2024-07-18 WO disclosed
WO-2024144246-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING SAME 솔루스첨단소재 주식회사 2024-07-04 WO disclosed
US-11903311-B2 Heterocyclic compound and organic light emitting device comprising the same LG CHEM, LTD. (KR) 2024-02-13 US disclosed
CN-117377659-A Compound for organic electric element, organic electric element using the same, and electronic device using the same 德山新勒克斯有限公司 2024-01-09 CN disclosed
US-11696501-B2 Compound for organic electronic element, organic electronic element using the same, and an electronic device thereof DUK SAN NEOLUX CO., LTD. (KR) 2023-07-04 US disclosed
US-11696501-B2 Compound for organic electronic element, organic electronic element using the same, and an electronic device thereof DUK SAN NEOLUX CO., LTD. (KR) 2023-07-04 US disclosed
WO-2023113381-A1 COMPOUND FOR ORGANIC ELECTRICAL ELEMENT, ORGANIC ELECTRICAL ELEMENT USING SAME, AND ELECTRONIC DEVICE THEREOF 덕산네오룩스 주식회사 2023-06-22 WO disclosed
CN-116023373-A Luminescent material, application thereof and organic electroluminescent device comprising luminescent material 清华大学 2023-04-28 CN disclosed
US-7390670-B2 Signalling compounds and methods for detecting hydrogen peroxide LUMIGEN, INC. (US) 2008-06-24 US disclosed
US-7390670-B2 Signalling compounds and methods for detecting hydrogen peroxide LUMIGEN, INC. (US) 2008-06-24 US disclosed
US-7365198-B2 Silyl compound, light emitting material, and organic light emitting device using the same CANON KABUSHIKI KAISHA (JP) 2008-04-29 US disclosed
WO-2008015945-A1 ORGANIC LUMINESCENT DEVICE AND BENZO[k]FLUORANTHENE COMPOUND CANON KABUSHIKI KAISHA (JP) 2008-02-07 WO disclosed
US-20070205715-A1 SILYL COMPOUND, LIGHT EMITTING MATERIAL, AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME CANON KABUSHIKI KAISHA (JP) 2007-09-06 US disclosed
EP-1506190-B1 (IMIDAZOL-1-YL-METHYL)-PYRIDAZINE AS NMDA RECEPTOR BLOCKER HOFFMANN LA ROCHE (CH) 2006-06-14 EP disclosed
US-7005432-B2 Substituted imidazol-pyridazine derivatives HOFFMAN-LA ROCHE INC. (US) 2006-02-28 US disclosed
EP-1506190-A1 (IMIDAZOL-1-YL-METHYL)-PYRIDAZINE AS NMDA RECEPTOR BLOCKER F. HOFFMANN-LA ROCHE AG (CH) 2005-02-16 EP disclosed
US-20030229096-A1 Substituted imidazol-pyridazine derivatives EVOTEC INTERNATIONAL GMBH (DE) 2003-12-11 US disclosed
WO-2003097637-A1 (IMIDAZOL-1-YL-METHYL)-PYRIDAZINE AS NMDA RECEPTOR BLOCKER F. HOFFMANN-LA ROCHE AG (CH) 2003-11-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12091401-B2 Nitrogen-heterocyclic compound, display panel and display apparatus C3AR1, C1S, C5 LPL 3054/4885LIPG 4488/4885TRPM4 3551/4885
US-11696501-B2 Compound for organic electronic element, organic electronic element using the same, and an electronic device thereof NFE2L2, AGO2, AOC2 LPL 1615/4885LIPG 1731/4885TRPM4 654/4885
US-20070205715-A1 SILYL COMPOUND, LIGHT EMITTING MATERIAL, AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME LAS1L, CCNL2, EML4 LPL 1558/4885LIPG 2825/4885TRPM4 487/4885
US-11903311-B2 Heterocyclic compound and organic light emitting device comprising the same CYP1A1, CYP1B1, CHRM1 LPL 3195/4885LIPG 4673/4885TRPM4 736/4885
US-20030229096-A1 Substituted imidazol-pyridazine derivatives GRIN2B, GRIN2A, GRIN2C LPL 4626/4885LIPG 4808/4885TRPM4 359/4885
US-12167689-B2 Heterocyclic compound and organic light emitting device comprising the same C1S, ARRB1, CRY1 LPL 2818/4885LIPG 4464/4885TRPM4 2260/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.